Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations

Roflumilast is given as an add-on to inhalation medication in patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis. Animal experiments have documented deleterious effects of roflumilast in bacterial infections, but trials have not reported the risk of bacterial infection...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard, Jens-Ulrik Stæhr Jensen
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2020-05-01
Collection:Journal of Clinical Medicine
Sujets:
COPD
roflumilast
hospitalization-requiring pneumonia
mortality
Accès en ligne:https://www.mdpi.com/2077-0383/9/5/1442
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires